Literature DB >> 20355053

Protective effects of enzymatic digest from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells.

Seung-Hong Lee1, Soo-Jin Heo, Ji-Young Hwang, Ji-Sook Han, You-Jin Jeon.   

Abstract

BACKGROUND: Antioxidants can prevent pathological damage caused by hyperglycaemia-induced oxidative stress associated with diabetes. In the present study, we investigated whether the brown alga Ecklonia cava has protective effects against high glucose-induced oxidative stress in Human umbilical vein endothelial cells (HUVECs). For that purpose, we prepared an enzymatic digest from E. cava (ECC) by using the carbohydrate, Celluclast.
RESULTS: High glucose treatment induced HUVECs cell death, but ECC, at a concentration of 10 or 100 microg mL(-1), significantly inhibited the high glucose-induced cytotoxicity. Furthermore, treatment with ECC dose-dependently decreased thiobarbituric acid reactive substances (TBARS), intracellular generation of reactive oxygen species, and the nitric oxide level increased by high glucose. In addition, ECC treatment increased activities of antioxidant enzymes including catalase, superoxide dismutase and glutathione peroxidase in high-glucose pretreated HUVECs. High glucose levels induced the overexpression of inducible nitric oxide synthase, cyclooxygenase-2 and nuclear factor-kappa B proteins in HUVECs, but ECC treatment reduced the overexpression of these proteins.
CONCLUSION: These results suggest that ECC is a potential therapeutic agent that will reduce the damage caused by hyperglycaemia-induced oxidative stress associated with diabetes. (c) 2009 Society of Chemical Industry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20355053     DOI: 10.1002/jsfa.3833

Source DB:  PubMed          Journal:  J Sci Food Agric        ISSN: 0022-5142            Impact factor:   3.638


  8 in total

1.  α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy.

Authors:  Xianwen Yi; Volker Nickeleit; Leighton R James; Nobuyo Maeda
Journal:  J Diabetes Complications       Date:  2010-08-30       Impact factor: 2.852

2.  Proanthocyanidin Attenuation of Oxidative Stress and NF- κ B Protects Apolipoprotein E-Deficient Mice against Diabetic Nephropathy.

Authors:  Abdulrahman L Al-Malki; Ahmed Amir Radwan Sayed; Haddad A El Rabey
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-18       Impact factor: 2.629

3.  Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.

Authors:  Rajesh A Maheshwari; R Balaraman; Ashim K Sen; A K Seth
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

4.  Persicarin isolated from Oenanthe javanica protects against diabetes-induced oxidative stress and inflammation in the liver of streptozotocin-induced type 1 diabetic mice.

Authors:  Joo Young Lee; Min Yeong Kim; Sung Ho Shin; Mi-Rae Shin; O Jun Kwon; Tae Hoon Kim; Chan Hum Park; Jeong Sook Noh; Man Hee Rhee; Seong-Soo Roh
Journal:  Exp Ther Med       Date:  2017-02-10       Impact factor: 2.447

5.  Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats.

Authors:  Rajesh Maheshwari; Ramachandran Balaraman; Ashim Kumar Sen; Disha Shukla; Avinash Seth
Journal:  Ren Fail       Date:  2016-11-13       Impact factor: 2.606

6.  Pyrogallol-Phloroglucinol-6,6'-Bieckol from Ecklonia cava Improved Blood Circulation in Diet-Induced Obese and Diet-Induced Hypertension Mouse Models.

Authors:  Myeongjoo Son; Seyeon Oh; Hye Sun Lee; BoMi Ryu; Yunfei Jiang; Ji Tae Jang; You-Jin Jeon; Kyunghee Byun
Journal:  Mar Drugs       Date:  2019-05-08       Impact factor: 5.118

Review 7.  Potential Bioactive Compounds from Seaweed for Diabetes Management.

Authors:  Yusrizam Sharifuddin; Yao-Xian Chin; Phaik-Eem Lim; Siew-Moi Phang
Journal:  Mar Drugs       Date:  2015-08-21       Impact factor: 5.118

8.  Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.

Authors:  Ji-Young Park; Jang Hoon Kim; Jung Min Kwon; Hyung-Jun Kwon; Hyung Jae Jeong; Young Min Kim; Doman Kim; Woo Song Lee; Young Bae Ryu
Journal:  Bioorg Med Chem       Date:  2013-04-22       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.